Australia markets closed

ZyVersa Therapeutics, Inc. (ZVSA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
5.28-0.32 (-5.71%)
At close: 04:00PM EDT
5.34 +0.06 (+1.14%)
After hours: 07:57PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. Estimate-3.7-3.75-15.05-94.9
Low estimate-5.4-5.3-22.7-185
High estimate-2-2.2-7.4-4.8
Year ago EPSN/AN/A-1,089.7-15.05
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings historyInvalid DateInvalid Date29/09/202330/12/2023
Est. EPSN/AN/A-56-21.4
Actual EPSN/AN/A-31.5-136.8
DifferenceN/AN/A24.5-115.4
Surprise %N/AN/A43.80%-539.30%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-3.7-3.75-15.05-94.9
7 days ago-3.7-3.75-15.05-94.9
30 days ago-0.37-0.37-1.5-9.49
60 days ago-1.46-1.46-5.75-9.49
90 days ago-1.46-1.46-5.75-9.49
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesZVSAIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year98.60%N/AN/AN/A
Next year-530.60%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A